The influence of inorganic phosphate on the activity of adenosine kinase

被引:27
|
作者
Maj, M [1 ]
Singh, B [1 ]
Gupta, RS [1 ]
机构
[1] McMaster Univ, Dept Biochem, Hamilton, ON L8N 3Z5, Canada
来源
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY | 2000年 / 1476卷 / 01期
关键词
adenosine kinase; phosphate; adenosine; substrate inhibition; substrate affinity;
D O I
10.1016/S0167-4838(99)00220-4
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The enzyme adenosine kinase (AK; EC 2.7.1.20) shows a dependence upon inorganic phosphate (Pi) for activity. The degree of dependence varies among enzyme sources and the pH at which the activity is measured. At physiological pH, recombinant AK from Chinese hamster ovary (CHO) cells and AK from beef liver (BL) show higher affinities for the substrate adenosine (Ado), larger maximum velocities and lower sensitivities to substrate inhibition in the presence of Pi. At pH 6.2, both BL and CHO AK exhibit almost complete dependence on the presence of Pi for activity. The data show that both enzymes exhibit increasing relief from substrate inhibition upon increasing Pi and the inhibition of BL AK is almost completely alleviated by the addition of 50 mM Pi. The affinity of CHO AK for Ado increases asymptotically from K-m 6.4 mu M to a limit of 0.7 mu M upon the addition of increasing Pi from 1 to 50 mM. The concentration of Ado necessary to invoke substrate inhibition also increases asymptotically from K-i 32 mu M to a limit of 69 mu M at saturating concentrations of phosphate. In the presence of increasing amounts of Pi the maximal velocity of activity increases hyperbolically. The effect that phosphate exerts on AK may be either to protect the enzyme from inactivation at high adenosine and H+ concentrations or to stabilize substrate binding at the active site. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:33 / 42
页数:10
相关论文
共 50 条
  • [21] Inhibition of adenosine kinase by phosphonate and bisphosphonate derivatives
    Jae Park
    Bhag Singh
    Radhey S. Gupta
    Molecular and Cellular Biochemistry, 2006, 283 : 11 - 21
  • [22] Adenosine kinase: A key regulator of purinergic physiology
    Boison, Detlev
    Jarvis, Michael F.
    BIOCHEMICAL PHARMACOLOGY, 2021, 187
  • [23] Inhibition of adenosine kinase by phosphonate and bisphosphonate derivatives
    Park, J
    Singh, B
    Gupta, RS
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2006, 283 (1-2) : 11 - 21
  • [24] The support of adenosine release from adenosine kinase deficient ES cells by silk substrates
    Uebersax, Lorenz
    Fedele, Denise E.
    Schumacher, Claudia
    Kaplan, David L.
    Merkle, Hans P.
    Boison, Detlev
    Meinel, Lorenz
    BIOMATERIALS, 2006, 27 (26) : 4599 - 4607
  • [25] Site and event specific increase of striatal adenosine release by adenosine kinase inhibition in rats
    Britton, DR
    Mikusa, J
    Lee, CH
    Jarvis, MF
    Williams, M
    Kowaluk, EA
    NEUROSCIENCE LETTERS, 1999, 266 (02) : 93 - 96
  • [26] Adenosine-Metabolizing Enzymes, Adenosine Kinase and Adenosine Deaminase, in Cancer
    Zhulai, Galina
    Oleinik, Eugenia
    Shibaev, Mikhail
    Ignatev, Kirill
    BIOMOLECULES, 2022, 12 (03)
  • [27] Therapeutic potential of adenosine kinase inhibition-Revisited
    Jarvis, Michael F.
    PHARMACOLOGY RESEARCH & PERSPECTIVES, 2019, 7 (04):
  • [28] Overexpression of adenosine kinase in epileptic hippocampus contributes to epileptogenesis
    Gouder, N
    Scheurer, L
    Fritschy, JM
    Boison, D
    JOURNAL OF NEUROSCIENCE, 2004, 24 (03) : 692 - 701
  • [29] Role of Adenosine Kinase Inhibitor in Adenosine Augmentation Therapy for Epilepsy: A Potential Novel Drug for Epilepsy
    Wang, Xiongfei
    Li, Tianfu
    CURRENT DRUG TARGETS, 2020, 21 (03) : 252 - 257
  • [30] Adenosine Kinase on Deoxyribonucleic Acid Methylation: Adenosine Receptor-Independent Pathway in Cancer Therapy
    Luo, Hao-Yun
    Shen, Hai-Ying
    Perkins, R. Serene
    Wang, Ya-Xu
    FRONTIERS IN PHARMACOLOGY, 2022, 13